Your browser doesn't support javascript.
loading
Long-Term Electrical and Mechanical Function Monitoring of a Human-on-a-Chip System.
Oleaga, Carlota; Lavado, Andrea; Riu, Anne; Rothemund, Sandra; Carmona-Moran, Carlos A; Persaud, Keisha; Yurko, Andrew; Lear, Jennifer; Narasimhan, Narasimhan Sriram; Long, Christopher J; Sommerhage, Frank; Bridges, L Richard; Cai, Yunqing; Martin, Candace; Schnepper, Mark T; Goswami, Arindom; Note, Reine; Langer, Jessica; Teissier, Silvia; Cotovio, José; Hickman, James J.
Afiliação
  • Oleaga C; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Lavado A; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Riu A; L'Oreal Research, and Innovation Division, Aulnay-sous-Bois, France.
  • Rothemund S; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Carmona-Moran CA; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Persaud K; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Yurko A; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Lear J; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Narasimhan NS; Hesperos, Inc., 3259 Progress Dr, Room 158, Orlando, FL 32826.
  • Long CJ; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Sommerhage F; Hesperos, Inc., 3259 Progress Dr, Room 158, Orlando, FL 32826.
  • Bridges LR; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Cai Y; Hesperos, Inc., 3259 Progress Dr, Room 158, Orlando, FL 32826.
  • Martin C; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Schnepper MT; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Goswami A; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Note R; NanoScience Technology Center, University of Central Florida, 12424 Research Parkway Suite 400, Orlando, FL 32826.
  • Langer J; L'Oreal Research, and Innovation Division, Aulnay-sous-Bois, France.
  • Teissier S; L'Oreal Research, and Innovation Division, Clark, NJ.
  • Cotovio J; L'Oreal Research, and Innovation Division, Aulnay-sous-Bois, France.
  • Hickman JJ; L'Oreal Research, and Innovation Division, Aulnay-sous-Bois, France.
Adv Funct Mater ; 29(8)2019 Feb 21.
Article em En | MEDLINE | ID: mdl-35586798
ABSTRACT
The goal of human-on-a-chip systems is to capture multi-organ complexity and predict the human response to compounds within physiologically relevant platforms. The generation and characterization of such systems is currently a focal point of research given the long-standing inadequacies of conventional techniques for predicting human outcome. Functional systems can measure and quantify key cellular mechanisms that correlate with the physiological status of a tissue, and can be used to evaluate therapeutic challenges utilizing many of the same endpoints used in animal experiments or clinical trials. Culturing multiple organ compartments in a platform creates a more physiologic environment (organ-organ communication). Here is reported a human 4-organ system composed of heart, liver, skeletal muscle and nervous system modules that maintains cellular viability and function over 28 days in serum-free conditions using a pumpless system. The integration of non-invasive electrical evaluation of neurons and cardiac cells and mechanical determination of cardiac and skeletal muscle contraction allows the monitoring of cellular function especially for chronic toxicity studies in vitro. The 28 day period is the minimum timeframe for animal studies to evaluate repeat dose toxicity. This technology could be a relevant alternative to animal testing by monitoring multi-organ function upon long term chemical exposure.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Adv Funct Mater Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Adv Funct Mater Ano de publicação: 2019 Tipo de documento: Article